Sudden cardiac death diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{Sara.Zand}} {{EdzelCo}} | {{CMG}} {{AE}} {{Sara.Zand}} {{EdzelCo}} | ||
==Overview== | |||
According to the 2017 Association for European Cardiovascular Pathologists guidelines, [[autopsy]] is done whenever [[sudden cardiac death]] ([[SCD]]) is suspected. | |||
==Diagnosis Study Of Choice== | ==Diagnosis Study Of Choice== | ||
Latest revision as of 02:56, 22 July 2023
|
Sudden cardiac death Microchapters |
|
Diagnosis |
|---|
|
Sudden cardiac death diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Sudden cardiac death diagnostic study of choice |
|
Risk calculators and risk factors for Sudden cardiac death diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Edzel Lorraine Co, DMD, MD[3]
Overview
According to the 2017 Association for European Cardiovascular Pathologists guidelines, autopsy is done whenever sudden cardiac death (SCD) is suspected.
Diagnosis Study Of Choice
- According to the 2017 Association for European Cardiovascular Pathologists guidelines, autopsy is done whenever sudden cardiac death (SCD) is suspected.
- Autopsy investigates whether:
- The mechanism of deathwas of mechanical or arrhythmic in nature
- The cause of SCD is of hereditary in origin requiring the need for screening and counseling for the next generations
- Third person involvement was present [1] [2]
References
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1007/s00428-017-2221-0. doi: 10.1007/s00428-017-2221-0. Check
|pmid=value (help). - ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1007/s00428-007-0505-5 doi: 10.1007/s00428-007-0505-5 Check
|pmid=value (help).